Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
US8367663B2 · kind B2 · utility
15Cited by
5References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2010 |
| Grant date | Feb 5, 2013 |
| Priority date | — |
| Expiry date | Jul 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.